Our broad portfolio consists of multiplex panels that allow you to choose, within the panel, analytes that best meet your needs. On a separate tab you can choose the premixed cytokine format or a single plex kit.
Cell Signaling Kits & MAPmates™
Choose fixed kits that allow you to explore entire pathways or processes. Or design your own kits by choosing single plex MAPmates™, following the provided guidelines.
The following MAPmates™ should not be plexed together: -MAPmates™ that require a different assay buffer -Phospho-specific and total MAPmate™ pairs, e.g. total GSK3β and GSK3β (Ser 9) -PanTyr and site-specific MAPmates™, e.g. Phospho-EGF Receptor and phospho-STAT1 (Tyr701) -More than 1 phospho-MAPmate™ for a single target (Akt, STAT3) -GAPDH and β-Tubulin cannot be plexed with kits or MAPmates™ containing panTyr
.
Catalogue Number
Ordering Description
Qty/Pack
List
This item has been added to favorites.
Select A Species, Panel Type, Kit or Sample Type
To begin designing your MILLIPLEX® MAP kit select a species, a panel type or kit of interest.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
This item has been added to favorites.
Species
Panel Type
Selected Kit
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
96-Well Plate
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
Add Additional Reagents (Buffer and Detection Kit is required for use with MAPmates)
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Space Saver Option Customers purchasing multiple kits may choose to save storage space by eliminating the kit packaging and receiving their multiplex assay components in plastic bags for more compact storage.
This item has been added to favorites.
The Product Has Been Added To Your Cart
You can now customize another kit, choose a premixed kit, check out or close the ordering tool.
440345
MilliporeLysozyme, Human Neutrophil
Occurs in specific granules of human polymorphonuclear leukocytes and takes part in antibacterial activity of leukocytes.
More>>Occurs in specific granules of human polymorphonuclear leukocytes and takes part in antibacterial activity of leukocytes. Less<<
Lysozyme, Human Neutrophil: Malzeme Güvenlik Bilgi Formu (MSDS) veya SDS, Analiz Sertifikası (COA) ve Kalite Uygunluk Sertifikası (COQ), dosyalar, broşürler ve diğer dokümanlar.
The quantity field is empty. Please enter a quantity of 1 or more to add items to your cart.
Description
Overview
Native lysozyme from human neutrophils. Occurs in specific granules of human polymorphonuclear leukocytes and takes part in antibacterial activity of leukocytes. Hydrolyzes β1,4 linkages between N-acetylmuramic acid (2-acetamido-2-deoxy-3-O-[1′-carboxymethyl]-glucopyranose) residues in chitin.
Catalogue Number
440345
Brand Family
Calbiochem®
Synonyms
N-Acetylmuramyl Hydrolase, Muramidase
References
References
Lollike, K., et al. 1995. Leukemia 9, 206. Gordon, L.I., et al. 1979. J. Clin. Invest. 64, 226.
Product Information
CAS number
9001-63-2
Unit of Definition
One Shugar unit is defined as the amount of enzyme that will cause a decrease in absorbance of 0.001 at 450 nm per min due to lysis of <i>Micrococcus lysodeikticus</i> at 37°C, pH 7.0.
EC number
3.2.1.17
Form
Lyophilized
Formulation
Lyophilized from 100 mM NaCl, 50 mM sodium acetate buffer, pH 6.0.
Applications
Biological Information
Purity
≥95% by SDS-PAGE
Source
Prepared from blood that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
Specific Activity
≥ 30,000 shugar units/mg protein
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
RTECS
OL5987000
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code
Ambient Temperature Only
Toxicity
Standard Handling
Storage
-20°C
Do not freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C) for long term storage or refrigerate (4°C) for short term storage. Stock solutions are stable for up to 3 days at 4°C or for up to 1 year at -20°C.
Lysozyme, Human Neutrophil Certificates of Analysis
Title
Lot Number
440345
References
Reference overview
Lollike, K., et al. 1995. Leukemia 9, 206. Gordon, L.I., et al. 1979. J. Clin. Invest. 64, 226.
Data Sheet
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
Revision
14-November-2013 JSW
Synonyms
N-Acetylmuramyl Hydrolase, Muramidase
Description
Native lysozyme from human neutrophils. Occurs in specific granules of human polymorphonuclear leukocytes and takes part in antibacterial activity of leukocytes. Hydrolyzes β1,4-linkages between N-acetylmuramic acid (2-acetamido-2-deoxy-3-O-[1'-carboxymethyl]-glucopyranose) residues in chitin.
Form
Lyophilized
Formulation
Lyophilized from 100 mM NaCl, 50 mM sodium acetate buffer, pH 6.0.
Source
Prepared from blood that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
CAS number
9001-63-2
RTECS
OL5987000
EC number
3.2.1.17
Purity
≥95% by SDS-PAGE
Specific activity
≥ 30,000 shugar units/mg protein
Unit definition
One Shugar unit is defined as the amount of enzyme that will cause a decrease in absorbance of 0.001 at 450 nm per min due to lysis of Micrococcus lysodeikticus at 37°C, pH 7.0.
Solubility
Aqueous Buffers or H₂O
Storage
-20°C
Do Not Freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C) for long term storage or refrigerate (4°C) for short term storage. Stock solutions are stable for up to 3 days at 4°C or for up to 1 year at -20°C.
Toxicity
Standard Handling
Merck USA index
14, 5640
References
Lollike, K., et al. 1995. Leukemia 9, 206. Gordon, L.I., et al. 1979. J. Clin. Invest. 64, 226.